CSIMarket
 


Moderna Inc   (MRNA)
Other Ticker:  
 


Moderna Inc 's Free Cash Flow Margin by quarter

Trends, Rankings, Statistics



MRNA Free Cash Flow Margin (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Revenue Change 6462.07 % 22989.76 % 431893.13 % 309527.45 % 100431.82 %
Seq. Revenue Change 124.78 % 239.38 % 261.44 % 137.99 % 690.93 %
Revenue In Millions $4,354.00 $1,937.00 $570.75 $157.91 $66.35
Free Cash Flow Margin 93.32 % - - - -
Free Cash Flow Margin Total Ranking # 156 # 77 # 71 # 27 #
Free Cash Flow In Millions $4,063.00 $2,971.00 $1,264.29 $892.75 $-23.88
Y / Y Free Cash Flow Change - - - - -
Seq. Free Cash Flow Change 36.76 % - - - -


Commenting Second Quarter 2021 Free Cash Flow Margin
Company's Free Cash Flow Margin decreased in II. Quarter to 93.32 %, below company's average Free Cash Flow Margin.

Observing second quarter 2021 results within Biotechnology & Pharmaceuticals industry 6 other companies have achieved higher Free Cash Flow Margin. While Free Cash Flow Margin overall ranking has deteriorated compare to previous quarter from 77 to 156.

MRNA's Free Cash Flow Margin second quarter 2021 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 7
Healthcare Sector # 20
Overall # 156

Free Cash Flow Margin Statistics
High Average Low
565.35 % 182.44 % 0.63 %
(Sep 30 2020)   (Jun 30 2013)




Other Free Cash Flow Margin Profitability Ratios
MRNA's Cumulative Free Cash Flow Margin
Biotechnology & Pharmaceuticals Industry Free Cash Flow Margin Trends and Statistics
Healthcare Sector Free Cash Flow Margin Statistics
Free Cash Flow Margin Profitability Trends for overall market
MRNA's Free Cash Flow Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Margin
Lowest Ranking Free Cash Flow Margin
Free Cash Flow Margin Profit Margin for MRNA's Competitors
Free Cash Flow Margin Profit Margin for Moderna Inc 's Suppliers
Free Cash Flow Margin Profit Margin for MRNA's Customers

You may also want to know
MRNA's Annual Growth Rates MRNA's Profitability Ratios MRNA's Asset Turnover Ratio MRNA's Dividend Growth
MRNA's Roe MRNA's Valuation Ratios MRNA's Financial Strength Ratios MRNA's Free Cash Flow Growth
MRNA's Roa MRNA's Inventory Turnover Ratio MRNA's Growth Rates MRNA's Dividend Comparisons


Companies with similar Free Cash Flow Margin in the quarter ending Jun 30 2021, within Biotechnology & Pharmaceuticals Industry Free Cash Flow MarginJun 30 2021 MRQ Free Cash FlowJun 30 2021 MRQ Revenue
Protalix Biotherapeutics inc   101.38 %$ 6.516 $ 6.427 
Royalty Pharma Plc  95.81 %$ 531.720 $ 554.963 
Tarsus Pharmaceuticals Inc   93.34 %$ 20.551 $ 22.017 
Moderna Inc   93.32 %$ 4,063.000 $ 4,354.000 
Crispr Therapeutics Ag  89.60 %$ 807.002 $ 900.701 
Vir Biotechnology Inc   79.10 %$ 140.058 $ 177.068 
Cure Pharmaceutical Holding Corp  53.06 %$ 1.119 $ 2.109 
Fulgent Genetics Inc   49.55 %$ 76.111 $ 153.616 
Novavax inc   48.46 %$ 144.412 $ 298.017 
Bio techne Corp  47.11 %$ 122.020 $ 259.028 
La Jolla Pharmaceutical Company  44.44 %$ 7.136 $ 16.059 
Biogen Inc   44.23 %$ 1,227.300 $ 2,775.000 
Gilead Sciences Inc   37.25 %$ 2,316.000 $ 6,217.000 
Ainos Inc  36.83 %$ 0.075 $ 0.203 
Neurocrine Biosciences Inc   35.72 %$ 103.200 $ 288.900 
Abbvie Inc   35.03 %$ 4,890.000 $ 13,959.000 
Halozyme Therapeutics Inc   29.12 %$ 39.731 $ 136.455 
Repligen Corp  23.10 %$ 37.651 $ 162.960 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HEI's Profile

Stock Price

HEI's Financials

Business Description

Fundamentals

Charts & Quotes

HEI's News

Suppliers

HEI's Competitors

Customers & Markets

Economic Indicators

HEI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071